Ethical Products Inc

Argus Analysts Upgrade Forest Laboratories, Inc. (FRX) Shares to "Buy"

Equities research analysts at Argus upgraded shares of Forest Laboratories, Inc. (NYSE: FRX) to a "buy" rating in a research note to investors on Wednesday. The analysts currently have a $46.00 price target on the stock.

Separately, analysts at Goldman Sachs (NYSE: GS) reiterated a "neutral" rating on shares of Forest Laboratories, Inc. in a research note to investors on Tuesday, June 14th. Also, analysts at JPMorgan Chase & Co. (NYSE: JPM) upgraded shares of Forest Laboratories, Inc. from a "neutral" rating to an "overweight" rating in a research note to investors on Friday, June 3rd. They now have a $41.00 price target on the stock.

Shares of Forest Laboratories, Inc. opened at 40.15 on Thursday. Forest Laboratories, Inc. has a 52 week low of $24.17 and a 52 week high of $40.29. The stock's 50-day moving average is $36.0 and its 200-day moving average is $33.38. The company has a market cap of $11.489 billion and a price-to-earnings ratio of 11.18.

Forest Laboratories, Inc. last announced its quarterly results on Tuesday, April 19th. The company reported $1.12 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $1.07 EPS by $0.05. During the same quarter in the prior year, the company posted $0.83 earnings per share. The company’s quarterly revenue was up 9.70% on a year-over-year basis. On average, analysts predict that Forest Laboratories, Inc. will post $0.94 EPS next quarter.

Forest Laboratories, Inc. (Forest) and its subsidiaries develop, manufacture and sell branded forms of ethical drug products. The Company’s United States products are marketed directly, or detailed, to physicians by its salesforces. It also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. The Company’s products include Lexapro, its SSRI for the treatment of major depression in adults and adolescents and GAD in adults; Namenda, its N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension, and Savella an serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia. The Company’s United Kingdom and Ireland subsidiaries sell both ethical products and over-the-counter preparations. Their products include Sudocrem, Colomycin, Infacol and Exorex.

These Stocks Reached 52-Week Highs As Tuesday Market Climb ...

Here are 14 stocks that hit 52-week highs in today’s trading . Note that this list excludes all stocks with a market capitalization less than $10 billion:

McDonald’s Corp. ( NYSE:MCD ): Up 0.13% to $82.80. McDonald’s Corporation operates and franchises fast-food restaurants worldwide. The Company’s franchised and company operated fast food restaurants offer a variety of low price fast foods in locations around the world. Unitedhealth Group, Inc. ( NYSE:UNH ): Up 1.83% to $52.21. UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers. Colgate-Palmolive Co. ( NYSE:CL ): Down 0.21% to $88.92. Colgate-Palmolive Company is a consumer products company that markets its products throughout the world. The Company’s products include toothpaste, toothbrushes, shampoos, deodorants, bar and liquid soaps, dishwashing liquid, and laundry products, as well as pet nutrition products for cats and dogs. Baxter International Inc. ( NYSE:BAX ): Down 0.22% to $59.80. Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories. Dominion Resources, Inc. ( NYSE:D ): Up 0.15% to $48.23. Dominion Resources, Inc., a diversified utility holding company, generates, transmits, distributes, and sells electric energy in Virginia and northeastern North Carolina. The Company produces, transports, distributes, and markets natural gas to customers in the Northeast and Mid-Atlantic regions of the United States. Northrop Grumman Corporation ( NYSE:NOC ): Up 1.25% to $66.55. Northrop Grumman Corporation is a global security company. The Company provides systems, products, and solutions in aerospace, electronics, information systems, shipbuilding and technical services to government and commercial customers worldwide.

Pet business

Baui Waui Adventure Products Inc. Berolina Imports Inc. Biclux International ... Ralph Inc. Eagle Importing Essex Topcrop sales Ltd. Ethical Products Inc. ...

Tropical fish hobbyist

... Inc.. a UPG Aquatic Company wavwrnannelandcom Petscape Pet Products Inc. www ... Ethical Products Inc. www.ethicalpet.com Florida AquaFarms Inc. ...

Standard & Poor's register of corporations, directors and executives

Fluorescent Products, Inc.) DYNA-VEYOR. INC EMPIRE LUMBER & M1LLWORK CO. EPOLIN INC. ETHICAL PRODUCTS, INC. EUREKA SPRINGS CO.. INC. ...

Dwell

D Cy-Purr Mouse Ethical Products, Inc. $6.99 How about the name of the company? Ethical Products, Inc. Makes me wonder what else they produce. ...

Hardware age

Lead-lined LEADS, Dog American Leather Specialties Corp 148 Lafayette St NY 13 Decker JC Inc Montgomery Pa 17752 Ethical Products Inc 47 Bruen Newark NJ ...